Mometasone + Formoterol Suppliers & Bulk Manufacturers
Available Forms: Inhaler(MDI)
Available Strengths: 100 mcg/5 mcg , 200 mcg/5 mcg
Reference Brands: Dulera®(US)
Category:
Respiratory Disorder
Mometasone + Formoterol, sold as Dulera® in the U.S., is a combination inhaler for asthma management. It pairs Mometasone furoate (ICS) with Formoterol fumarate (LABA) to reduce inflammation and improve airflow. Available as a metered-dose inhaler in 100/5 mcg and 200/5 mcg strengths, Dulera® offers effective, long-term asthma control.
Mometasone + Formoterol is available in Inhaler(MDI)
and strengths such as 100 mcg/5 mcg , 200 mcg/5 mcg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Mometasone + Formoterol is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Mometasone + Formoterol can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Mometasone + Formoterol, marketed as Dulera® in the United States, is a combination inhaler used to manage asthma in patients aged 12 years and older. It combines Mometasone furoate, an inhaled corticosteroid (ICS) that reduces airway inflammation, with Formoterol fumarate, a long-acting beta-agonist (LABA) that relaxes bronchial muscles for easier breathing. This powerful duo helps control asthma symptoms and prevent attacks. Dulera® is available in metered-dose inhaler (MDI) form in two strengths: 100 mcg/5 mcg and 200 mcg/5 mcg. Widely prescribed in the U.S., it is a key component in respiratory therapy and pharma B2B exports.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing